Bushu Pharma was nominated for the Healthcare Asia Pharma Awards and provided detailed information about its initiatives related to the SDGs (Sustainable Development Goals). The company’s goals, significance, and methods for overcoming challenges were highly evaluated against the awards’ criteria for the “ESG Program of the Year” and “Sustainability Initiative of the Year,” leading to this prestigious recognition.

In receiving these awards, three of Bushu Pharma’s environmental sustainability efforts were particularly commended:

• The installation of 2,300 solar panels at the Kawagoe plant: Reducing CO2 emissions by 600 tons annually.

• Blister packs: Transitioning from plastic to paper resources.

• Stringent wastewater management: Keeping BOD (Biological Oxygen Demand) levels below legal limits.

The selection for these awards was conducted by an external committee, including members from global consulting firms, who provided an objective evaluation of the nominations.

Under its mission of “supporting the global healthcare industry to create a healthier tomorrow,” Bushu Pharma continues to commit to environmentally conscious activities and aims to resolve issues with clear goals in mind.

For more information, visit https://healthcareasiamagazine.com/co-written-partner/event-news/bushu-pharmaceuticals-brings-home-two-wins-healthcare-asia-pharma-awards-2024.